SCHEMBL28901778

SCHEMBL28901778

CC1(N)NC=C([N+](=O)[O-])C=C1N

nearest known ligand 0.31

Predicted protein targets (top 9)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.31
CYP3A4 P08684 2/20 0.31
POLB P06746 1/20 0.31
HTT P42858 1/20 0.31
TDP1 Q9NUW8 1/20 0.31
CYP1A2 P05177 1/20 0.30
CYP2C9 P11712 1/20 0.30
CYP2C19 P33261 1/20 0.30
TSHR P16473 2/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28897810 0.71 ALDH1A1 (0.31) ALDH1A1CYP3A4POLBHTTTDP1
SCHEMBL19263764 0.63 MEN1 (0.39) ALDH1A1
SCHEMBL19086367 0.62
SCHEMBL28586401 0.61 ALDH1A1 (0.31) ALDH1A1CYP3A4POLBHTTTDP1
SCHEMBL30820070 0.60 ALDH1A1 (0.32) ALDH1A1CYP3A4POLBHTTTDP1
SCHEMBL28957954 0.55
SCHEMBL10851926 0.55
SCHEMBL2043583 0.54
SCHEMBL7952000 0.54 LMNA (0.31) ALDH1A1CYP3A4CYP1A2TSHR
SCHEMBL2037894 0.52

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109328059-B Selective inhibitors of clinically important mutants of EGFR tyrosine kinase CS制药技术有限公司 2021-08-17 CN disclosed
CN-111892579-A Kinase inhibitor 上海复尚慧创医药研究有限公司 2020-11-06 CN disclosed
CN-111875585-A Kinase inhibitor 上海复尚慧创医药研究有限公司 2020-11-03 CN disclosed
CN-109328059-A Selective inhibitors of clinically important mutants of EGFR tyrosine kinase CS制药技术有限公司 2019-02-12 CN disclosed